[1]
Ademi, Z., Pfeil, A.M., Hancock, E., Trueman, D., Haroun, R., Deschaseaux, C. and Schwenkglenks, M. 2017. Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Swiss Medical Weekly. 147, 4546 (Nov. 2017), w14533. DOI:https://doi.org/10.4414/smw.2017.14533.